Amoxicillin (Amoxicillin)

Trade Name : Amoxicillin

West-Ward Pharmaceuticals Corp

POWDER, FOR SUSPENSION

Strength 200 mg/5mL

AMOXICILLIN Penicillin-class Antibacterial [EPC],Penicillins [CS]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Amoxicillin (Amoxicillin) which is also known as Amoxicillin and Manufactured by West-Ward Pharmaceuticals Corp. It is available in strength of 200 mg/5mL per ml. Read more

Amoxicillin (Amoxicillin) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of Amoxicillin and other antibacterial drugs, Amoxicillin for Oral Suspensionu00a0should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
  • Amoxicillin for Oral Suspension is indicated in the treatment of infections due to susceptible (ONLY u03b2-lactamaseu2013negative) isolates of the designated bacteria in the conditions listed below:
  • Amoxicillin for Oral Suspension is a penicillin-class antibacterial indicated for treatment of infections due to susceptible strains of designated microorganisms.u2022 Infections of the ear, nose, throat, genitourinary tract, skin and skin structure, and lower respiratory tract. (1.1 u2013 1.5)u2022 In combination for treatment of H. pylori infection and duodenal ulcer disease. (1.6, 1.7)
  • No data
  • In adults, 750-1750 mg/day in divided doses every 8-12 hours. In Pediatric Patients > 3 Months of Age, 20-45 mg/kg/day in divided doses every 8-12u00a0 hours. Refer to full prescribing information for specific dosing regimens. (2.1, 2.2, 2.3)n
  • Treatment of gonorrhea is 3 grams as a single oral dose. (2.1)n
  • The upper dose for neonates and infants u2264 3 months is 30 mg/kg/day divided every 12 hours. (2.2)n
  • Dosing for Infection: Triple therapy: 1 gram Amoxicillin, 500 mg clarithromycin, and 30 mg lansoprazole, all given twice daily (every 12 hours) for 14 days. Dual therapy: 1 gram Amoxicillin and 30 mg lansoprazole, each given three times daily (every 8 hours) for 14 days. (2.3)n
  • Reduce the dose in patients with severe renal impairment (GFR <30 mL/min). (2.4)u00a0u00a0
  • Amoxicillin for Oral Suspension:125 mg/5 mL, 200 mg/5 mL, 250 mg/5 mL, 400 mg/5 mL. Each 5 mL of reconstituted fruity flavored suspension contains 125 mg, 200 mg, 250 mg or 400 mg Amoxicillin as the trihydrate.
  • for Oral Suspension: 125 mg/5 mL,u00a0200 mg/5 mL, 250 mg/5 mL, 400 mg/5 mL (3)
  • Amoxicillin is contraindicated in patients who have experienced a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to Amoxicillin or to other u03b2-lactam antibiotics (e.g., penicillins and cephalosporins).
  • History of a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to Amoxicillin or to other beta-lactams (e.g., penicillins or cephalosporins) (4).
  • No data
  • Anaphylactic reactions: Serious and occasionally fatal anaphylactic reactions have been reported in patients on penicillin therapy. Serious anaphylactic reactions require immediate emergency treatment with supportive measures. (5.1)n
  • Clostridium difficile
  • The following are discussed in more detail in other sections of the labeling:u2022 Anaphylactic reactions [see Warnings and Precautions (5.1)]u2022 CDAD [see Warnings and Precautions (5.2)]
  • The most common adverse reactions (> 1%) observed in clinical trials ofu00a0Amoxicillin for oral suspension were diarrhea, rash, vomiting,u00a0and nausea. (6.1)
  • To report SUSPECTED ADVERSE REACTIONS, contact West-Ward Pharmaceutical Corp. at 1-877-233-2001, or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
  • No data
  • Probenicid decreases renal tubular secretion of Amoxicillin which may result in increased blood levels of Amoxicillin. (7.1)
  • Concomitant use of Amoxicillin and oral anticoagulants may increase the prolongation of prothrombin time. (7.2)
  • Coadministration with allopurinol increases the risk of rash. (7.3)
  • Amoxicillin may reduce the efficacy of oral contraceptives. (7.4)
  • No data
  • Pediatric: Modify dose in patients 12 weeks or younger (u2264 3 months).(8.4)
  • In case of overdosage, discontinue medication, treat symptomatically, and institute supportive measures as required. A prospective study of 51 pediatric patients at a poison control center suggested that overdosages of less than 250 mg/kg of Amoxicillin are not associated with significant clinical symptoms. Interstitial nephritis resulting in oliguric renal failure has been reported in a small number of patients after overdosage with Amoxicillin.
  • Crystalluria, in some cases leading to renal failure, has also been reported after Amoxicillin overdosage in adult and pediatric patients. In case of overdosage, adequate fluid intake and diuresis should be maintained to reduce the risk of Amoxicillin crystalluria.
  • Renal impairment appears to be reversible with cessation of drug administration. High blood levels may occur more readily in patients with impaired renal function because of decreased renal clearance of Amoxicillin. Amoxicillin may be removed from circulation by hemodialysis.
  • Formulations of Amoxicillin for Oral Suspension, USP contain Amoxicillin, a semisynthetic antibiotic, an analog of ampicillin, with a broad spectrum of bactericidal activity against many Gram-positive and Gram-negative microorganisms. Chemically, it is (2,5,6)-6-[()-(-)-2-amino-2-(-hydroxyphenyl)acetamido]-3,3-dimethyl-7-oxo-4-thia-1-zabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate. It may be represented structurally as:
  • The Amoxicillin molecular formula is CHNOSu20223HO, and the molecular weight is 419.45.
  • Amoxicillinu00a0for Oral Suspension, USP:
  • No data
  • Long-term studies in animals have not been performed to evaluate carcinogenic potential. Studies to detect mutagenic potential of Amoxicillin alone have not been conducted; however, the following information is available from tests on a 4:1 mixture of Amoxicillin and potassium clavulanate. Amoxicillin and potassium clavulanate was non-mutagenic in the Ames bacterial mutation assay, and the yeast gene conversion assay. Amoxicillin and clavulanate potassium was weakly positive in the mouse lymphoma assay, but the trend toward increased mutation frequencies in this assay occurred at doses that were also associated with decreased cell survival. Amoxicillin and clavulanate potassium was negative in the mouse micronucleus test and in the dominant lethal assay in mice. Potassium clavulanate alone was tested in the Ames bacterial mutation assay and in the mouse micronucleus test, and was negative in each of these assays. In a multi-generation reproduction study in rats, no impairment of fertility or other adverse reproductive effects were seen at doses up to 500 mg/kg (approximately 2 times the 3 g human dose based on body surface area).
  • Randomized, double-blind clinical studies performed in the United States in patients with and duodenal ulcer disease (defined as an active ulcer or history of an ulcer within 1 year) evaluated the efficacy of lansoprazole in combination with Amoxicillin capsules and clarithromycin tablets as triple 14-day therapy, or in combination with Amoxicillin capsules as dual 14-day therapy, for the eradication of . Based on the results of these studies, the safety and efficacy of 2 different eradication regimens were established: Amoxicillin 1 gram twice daily/clarithromycin 500 mg twice daily/lansoprazole 30 mg twice daily (see Table 6). Amoxicillin 1 gram three times daily/lansoprazole 30 mg three times daily (see Table 7). All treatments were for 14 days. eradication was defined as 2 negative tests (culture and histology) at 4 to 6 weeks following the end of treatment. Triple therapy was shown to be more effective than all possible dual therapy combinations. Dual therapy was shown to be more effective than both monotherapies. Eradication of has been shown to reduce the risk of duodenal ulcer recurrence.
  • H. pylori
  • H. pylori
  • H. pylori
  • H. pylori
  • 1. Swanson-Biearman B, Dean BS, Lopez G, Krenzelok EP. The effects of penicillin and cephalosporin ingestions in children less than six years of age.Vetu00a0Hum Toxicol. 1988; 30: 66-67
  • Amoxicillin for Oral Suspension, USP:Each 5 mL of reconstituted fruity-flavored suspension contains 125, 200, 250, or 400 mg Amoxicillin as the trihydrate.
  • An- moxicillin forn- Oral Suspension, USP 125 mg/5ml
  • Amoxicillin for Oral Suspension, USP 200 mg/5mL
  • Amoxicillin for Oral Suspension, USP 250 mg/5mL
  • Amoxicillin for Oral Suspension, USP 400 mg/5mL
  • Store at 20u00b0 to 25u00b0C (68u00b0 to n- 77u00b0F ) [n- See USP Controlled Room Temperature]n- Array
  • No data
  • Distributed by:
  • West-Ward Pharmaceutical Corp.n
  • Eatontown, NJ 07724 USAu00a0u00a0u00a0u00a0
  • Manufactured by:n P.O. Box 182400Amman 11118 u2013 Jordanu00a0u00a0u00a0u00a0u00a0u00a0
  • Revised September 2018
  • Principal Display PanelNDC 0143-9888-01
  • AMOXICILLINFOR ORAL SUSPENSION, USPDye Free125 mg/ 5 mL *100u00a0mL (when reconstituted)Rx Only
  • Principal Display PanelNDC 0143-9886-01
  • AMOXICILLINFOR ORAL SUSPENSION, USPDye Free200u00a0mg/ 5 mL *100u00a0mL (when reconstituted)Rx Only
  • Principal Display PanelNDC 0143-9889-01
  • AMOXICILLINFOR ORAL SUSPENSION, USPDye Free250u00a0mg/ 5 mL *100u00a0mL (when reconstituted)Rx Only
  • Principal Display PanelNDC 0143-9887-01
  • AMOXICILLINFOR ORAL SUSPENSION, USPDye Free400u00a0mg/ 5 mL *100u00a0mL (when reconstituted)Rx Only

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71246 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.